These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 12492997)

  • 1. Topical prostaglandin analog (PGE2) in vitiligo--a preliminary study.
    Parsad D; Pandhi R; Dogra S; Kumar B
    Int J Dermatol; 2002 Dec; 41(12):942-5. PubMed ID: 12492997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of efficacy and safety of vitiligo treatment with micro-needling combined with N-Acetylcysteine and micro-needling alone: A double-blinded randomized controlled clinical trial.
    Atefi N; Ziaeifar E; Seirafianpour F; Sadeghzadeh-Bazargan A; Amin NG; Mozafarpoor S; Abouie A; Jafari MA; Goodarzi A
    J Cosmet Dermatol; 2024 Jun; 23(6):2220-2230. PubMed ID: 38470079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical application of simvastatin acid sodium salt and atorvastatin calcium salt in vitiligo patients. Results of the randomized, double-blind EVRAAS pilot study.
    Niezgoda A; Winnicki A; Krysiński J; Niezgoda P; Nowowiejska L; Czajkowski R
    Sci Rep; 2024 Jun; 14(1):14612. PubMed ID: 38918590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo.
    Kapoor R; Phiske MM; Jerajani HR
    Br J Dermatol; 2009 Apr; 160(4):861-3. PubMed ID: 19014395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New topical agents for hair growth.
    Roenigk HH
    Clin Dermatol; 1988; 6(4):119-21. PubMed ID: 3214817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandins protect against murine hair injury produced by ionizing radiation or doxorubicin.
    Malkinson FD; Geng L; Hanson WR
    J Invest Dermatol; 1993 Jul; 101(1 Suppl):135S-137S. PubMed ID: 8326147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bimatoprost 0.03% Solution for the Treatment of Nonfacial Vitiligo.
    Grimes PE
    J Drugs Dermatol; 2016 Jun; 15(6):703-10. PubMed ID: 27272076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of latanoprost on vitiligo: a preliminary comparative study.
    Anbar TS; El-Ammawi TS; Abdel-Rahman AT; Hanna MR
    Int J Dermatol; 2015; 54(5):587-93. PubMed ID: 25545321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of tissue levels of dickkopf-1 in androgenetic alopecia and alopecia areata.
    Fawzi MM; Mahmoud SB; Shaker OG; Saleh MA
    J Cosmet Dermatol; 2016 Mar; 15(1):10-5. PubMed ID: 26222765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Cistanche Tubulosa and Laminaria Japonica Extracts (MK-R7) Supplement in Preventing Patterned Hair Loss and Promoting Scalp Health.
    Seok J; Kim TS; Kwon HJ; Lee SP; Kang MH; Kim BJ; Kim MN
    Clin Nutr Res; 2015 Apr; 4(2):124-31. PubMed ID: 25954733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does prostaglandin D2 hold the cure to male pattern baldness?
    Nieves A; Garza LA
    Exp Dermatol; 2014 Apr; 23(4):224-7. PubMed ID: 24521203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatment and combination approaches for vitiligo: new insights, new developments.
    Hossani-Madani AR; Halder RM
    G Ital Dermatol Venereol; 2010 Feb; 145(1):57-78. PubMed ID: 20197746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
    Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M
    Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Evaluation of Efficacy and Safety of Tacrolimus and Dinoprostone Following Dermabrasion in Stable Vitiligo.
    Kaur J; Kumar S; Brar BK; Boparai AS
    J Drugs Dermatol; 2021 May; 20(5):519-522. PubMed ID: 33938708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of topical latanoprost in the treatment of eyelid vitiligo: A randomized, double-blind clinical trial study.
    Nowroozpoor Dailami K; Hosseini A; Rahmatpour Rokni G; Saeedi M; Morteza-Semnani K; Sadeghi Z; Ghasemzadeh Diva SM; Goldust M; Lotti T; Vojvodic A; Goren A; Sonthalia S; Rathod D
    Dermatol Ther; 2020 Jan; 33(1):e13175. PubMed ID: 31758835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo.
    Zaky MS; Atallah RB; El Abasy NTA; Elsaie ML
    Arch Dermatol Res; 2024 Jun; 316(7):350. PubMed ID: 38850408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual dimorphism in melanocyte stem cell behavior reveals combinational therapeutic strategies for cutaneous repigmentation.
    An L; Kim D; Donahue LR; Mejooli MA; Eom CY; Nishimura N; White AC
    Nat Commun; 2024 Jan; 15(1):796. PubMed ID: 38280858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of prostaglandin E2 versus prostaglandin F2 alpha assisted with narrowband-UVB in stable vitiligo.
    Neinaa YME; Mahmoud MAE; El Maghraby GM; Ibrahim ZAE
    Arch Dermatol Res; 2023 Nov; 315(9):2647-2653. PubMed ID: 37594537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiopathogenesis and Emerging Methods for Treatment of Vitiligo.
    Iwanowski T; Kołkowski K; Nowicki RJ; Sokołowska-Wojdyło M
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art.
    Diotallevi F; Gioacchini H; De Simoni E; Marani A; Candelora M; Paolinelli M; Molinelli E; Offidani A; Simonetti O
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.